{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:04:07Z","timestamp":1790730247210,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminarsinnuclearmedicine.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1053\/j.semnuclmed.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T07:15:17Z","timestamp":1471936517000},"page":"419-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Angiogenesis Imaging Using 68Ga-RGD PET\/CT: Therapeutic Implications"],"prefix":"10.1053","volume":"46","author":[{"given":"Jae Seon","family":"Eo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Min","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6801","key":"10.1053\/j.semnuclmed.2016.04.001_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.04.001_bib2","first-page":"1061","article-title":"Radiolabeled \u03b1v\u03b23 integrin antagonists: A new class of tracers for tumor targeting","volume":"40","author":"Haubner","year":"1999","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.04.001_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jlcr.2999","article-title":"Tracers for imaging receptor integrin \u03b1v\u03b23 expression","volume":"56","author":"Cai","year":"2013","journal-title":"J Labelled Comp Radiopharm"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.04.001_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00259-008-0757-6","article-title":"68Ga- and 111In-labelled DOTA-RGD peptides for imaging of \u03b1v\u03b23 integrin expression","volume":"35","author":"Decristoforo","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.04.001_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2967\/jnumed.107.047423","article-title":"Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice","volume":"49","author":"Jeong","year":"2008","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.04.001_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00259-007-0692-y","article-title":"68Ga-labeled multimeric RGD peptides for microPET imaging of integrin \u03b1v\u03b23 expression","volume":"35","author":"Li","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.04.001_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00259-008-1045-1","article-title":"68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: Promising agents for tumor integrin \u03b1v\u03b23 PET imaging","volume":"36","author":"Liu","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.04.001_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/1568009614666140403123452","article-title":"PET imaging with [68Ga]NOTA-RGD for prostate cancer: A comparative study with [18F]fluorodeoxyglucose and [18F]fluoroethylcholine","volume":"14","author":"Israel","year":"2014","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"10.1053\/j.semnuclmed.2016.04.001_bib9","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/bc200197h","article-title":"Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice","volume":"22","author":"Lang","year":"2011","journal-title":"Bioconjug Chem"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.04.001_bib10","doi-asserted-by":"crossref","first-page":"e37506","DOI":"10.1371\/journal.pone.0037506","article-title":"Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model","volume":"7","author":"Guo","year":"2012","journal-title":"PLos One"},{"issue":"10","key":"10.1053\/j.semnuclmed.2016.04.001_bib11","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00726-014-1788-x","article-title":"A direct comparison of tumor angiogenesis with 68Ga-labeled NGR and RGD peptides in HT-1080 tumor xenografts using microPET imaging","volume":"46","author":"Shao","year":"2014","journal-title":"Amino Acids"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.04.001_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s11307-013-0710-3","article-title":"Radiolabeled RGD tracer kinetics annotates differential \u03b1v\u03b23 integrin expression linked to cell intrinsic and vessel expression","volume":"16","author":"Alam","year":"2014","journal-title":"Mol Imaging Biol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2016.04.001_bib13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00259-011-1778-0","article-title":"[68Ga]NODAGA-RGD for imaging \u03b1v\u03b23 integrin expression","volume":"38","author":"Knetsch","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.04.001_bib14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2967\/jnumed.111.087700","article-title":"Novel 64Cu- and 68Ga-labeled RGD conjugates show improved PET imaging of \u03b1v\u03b23 integrin expression and facile radiosynthesis","volume":"52","author":"Dumont","year":"2011","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2016.04.001_bib15","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1021\/bc300348d","article-title":"68Ga small peptide imaging: Comparison of NOTA and PCTA","volume":"23","author":"Ferreira","year":"2012","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.04.001_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nucmedbio.2014.10.001","article-title":"[68Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging \u03b1v\u03b23 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation","volume":"42","author":"Knetsch","year":"2015","journal-title":"Nucl Med Biol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.04.001_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jlcr.3286","article-title":"Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68","volume":"58","author":"Zhai","year":"2015","journal-title":"J Label Comp Radiopharm"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.04.001_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nucmedbio.2012.08.006","article-title":"Be spoilt for choice with radiolabelled RGD peptides: Preclinical evaluation of 68Ga-TRAP(RGD)(3)","volume":"40","author":"Notni","year":"2013","journal-title":"Nucl Med Biol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2016.04.001_bib19","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1021\/bc200319q","article-title":"Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging","volume":"22","author":"Ma","year":"2011","journal-title":"Bioconjug Chem"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.04.001_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nucmedbio.2012.01.003","article-title":"RGD conjugates of the H2dedpa scaffold: Synthesis, labeling and imaging with 68Ga","volume":"39","author":"Boros","year":"2012","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.04.001_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nucmedbio.2012.09.006","article-title":"[68Ga]NS(3)-RGD and [68Ga] Oxo-DO3A-RGD for imaging \u03b1v\u03b23 integrin expression: Synthesis, evaluation, and comparison","volume":"40","author":"Knetsch","year":"2013","journal-title":"Nucl Med Biol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2016.04.001_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/ar800243b","article-title":"Ligands for mapping \u03b1v\u03b23-integrin expression in vivo","volume":"42","author":"Schottelius","year":"2009","journal-title":"Acc Chem Res"},{"issue":"15","key":"10.1053\/j.semnuclmed.2016.04.001_bib23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/cbic.201000386","article-title":"Multimerization of cRGD peptides by click chemistry: Synthetic strategies, chemical limitations, and influence on biological properties","volume":"11","author":"Wangler","year":"2010","journal-title":"Chembiochem"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.04.001_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00259-010-1615-x","article-title":"PET imaging of \u03b1v\u03b23 integrin expression in tumours with 68Ga-labelled mono-, di- and tetrameric RGD peptides","volume":"38","author":"Dijkgraaf","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.04.001_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2967\/jnumed.110.079707","article-title":"Development of small-animal PET prototype using silicon photomultiplier (SiPM): Initial results of phantom and animal imaging studies","volume":"52","author":"Kwon","year":"2011","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.04.001_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.nucmedbio.2012.02.006","article-title":"68Ga-NODAGA-RGD is a suitable substitute for 18F-Galacto-RGD and can be produced with high specific activity in a cGMP\/GRP compliant automated process","volume":"39","author":"Pohle","year":"2012","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.04.001_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/cbr.2012.1252","article-title":"The practicality of nanoceria-PAN-based 68Ge\/68Ga generator toward preparation of 68Ga-labeled cyclic RGD dimer as a potential PET radiotracer for tumor imaging","volume":"28","author":"Chakraborty","year":"2013","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.04.001_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.18632\/oncotarget.234","article-title":"Recent advances in anti-angiogenic therapy of cancer","volume":"2","author":"Samant","year":"2011","journal-title":"Oncotarget"},{"key":"10.1053\/j.semnuclmed.2016.04.001_bib29","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s00259-011-2001-z","article-title":"Radiopharmaceutical development of radiolabelled peptides","volume":"39","author":"Fani","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.04.001_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jlcr.2999","article-title":"RGD-based PET tracers for imaging receptor integrin \u03b1v \u03b23 expression","volume":"56","author":"Cai","year":"2013","journal-title":"J Labelled Comp Radiopharm"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.04.001_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/cbr.2011.1061","article-title":"Whole-body distribution and radiation dosimetry of 68Ga-NOTA-RGD: A positron emission tomography agent for angiogenesis imaging","volume":"27","author":"Kim","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.04.001_bib32","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00259-014-2744-4","article-title":"Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from 68Ga-RGD PET\/CT and 18F-FDG PET\/CT","volume":"41","author":"Yoon","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.04.001_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/cbr.2014.1781","article-title":"Integrin \u03b1v\u03b23 as a promising target to image neoangiogenesis using in-house generator-produced positron emitter 68Ga-Labeled DOTA-arginine-glycine-aspartic acid (RGD) ligand","volume":"30","author":"Vatsa","year":"2015","journal-title":"Cancer Biother Radiopharm"},{"issue":"11","key":"10.1053\/j.semnuclmed.2016.04.001_bib34","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1021\/mp5003224","article-title":"68Ga-PRGD2 PET\/CT in the evaluation of glioma: A prospective study","volume":"11","author":"Li","year":"2014","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1053\/j.semnuclmed.2016.04.001_bib35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2967\/jnumed.115.160648","article-title":"68Ga-NOTA-PRGD2 PET\/CT for integrin imaging in patients with lung cancer","volume":"56","author":"Zheng","year":"2015","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.04.001_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/CRD.0b013e3181620e3b","article-title":"Therapeutic angiogenesis: A new treatment approach for ischemic heart disease\u2014Part I","volume":"16","author":"Ahn","year":"2008","journal-title":"Cardiol Rev"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.04.001_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MCA.0b013e3283608c32","article-title":"Angiogenesis imaging in myocardial infarction using 68Ga-NOTA-RGD PET: Characterization and application to therapeutic efficacy monitoring in rats","volume":"24","author":"Eo","year":"2013","journal-title":"Coron Artery Dis"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.04.001_bib38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s11307-014-0752-1","article-title":"Dimeric [68Ga]DOTA-RGD peptide targeting \u03b1v\u03b23 integrin reveals extracellular matrix alterations after myocardial infarction","volume":"16","author":"Kiugel","year":"2014","journal-title":"Mol Imaging Biol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.04.001_bib39","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00259-013-2432-9","article-title":"MicroPET\/CT imaging of \u03b1v\u03b23 integrin via a novel 68Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction","volume":"40","author":"Menichetti","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2016.04.001_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/RLU.0000000000000426","article-title":"Is the change of integrin \u03b1v\u03b23 expression in the infarcted myocardium related to the clinical outcome?","volume":"39","author":"Luo","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2016.04.001_bib41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12149-013-0757-x","article-title":"Feasibility and kinetic characteristics of 68Ga-NOTA-RGD PET for in vivo atherosclerosis imaging","volume":"27","author":"Paeng","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.04.001_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2310\/7290.2012.00036","article-title":"Imaging of integrin \u03b1v\u03b23 expression using 68Ga-RGD positron emission tomography in pediatric cerebral infarct","volume":"12","author":"Choi","year":"2013","journal-title":"Mol Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2016.04.001_bib43","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2967\/jnumed.114.142430","article-title":"In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric moyamoya disease","volume":"55","author":"Kim","year":"2014","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2016.04.001_bib44","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1021\/mp5003202","article-title":"PET imaging of neovascularization with 68Ga-3PRGD2 for assessing tumor early response to endostar antiangiogenic therapy","volume":"11","author":"Shi","year":"2014","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1053\/j.semnuclmed.2016.04.001_bib45","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2967\/jnumed.114.137570","article-title":"Does imaging \u03b1v\u03b23 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?","volume":"55","author":"Rylova","year":"2014","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2016.04.001_bib46","first-page":"792","article-title":"DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy","volume":"24","author":"Otte","year":"1997","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.04.001_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.nucmedbio.2014.09.010","article-title":"Preparation and preclinical evaluation of 66Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical","volume":"42","author":"Lopez-Rodriguez","year":"2015","journal-title":"Nucl Med Biol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.04.001_bib48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nucmedbio.2013.12.003","article-title":"Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors","volume":"41","author":"Oxboel","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2016.04.001_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7150\/thno\/v01p0322","article-title":"Evaluation of in-labeled cyclic RGD peptides: Effects of peptide and linker multiplicity on their tumor uptake, excretion kinetics and metabolic stability","volume":"1","author":"Shi","year":"2011","journal-title":"Theranostics"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.04.001_bib50","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/cbr.2010.0825","article-title":"Development of a 177Lu-labeled RGD derivative for targeting angiogenesis","volume":"25","author":"Ju","year":"2010","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.04.001_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nucmedbio.2014.10.004","article-title":"Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using 90Y or 177Lu","volume":"42","author":"Kang","year":"2015","journal-title":"Nucl Med Biol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2016.04.001_bib52","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00259-009-1123-z","article-title":"68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging","volume":"36","author":"Liu","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2016.04.001_bib53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jlcr.3296","article-title":"Synthesis of 68Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging","volume":"58","author":"Yu","year":"2015","journal-title":"J Labelled Comp Radiopharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.04.001_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pep.2007.02.001","article-title":"A biologically active angiogenesis inhibitor, human serum albumin-TIMP-2 fusion protein, secreted from Saccharomyces cerevisiae","volume":"53","author":"Kang","year":"2007","journal-title":"Protein Expr Purif"},{"issue":"29","key":"10.1053\/j.semnuclmed.2016.04.001_bib55","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1016\/j.biomaterials.2011.06.007","article-title":"The use of the fusion protein RGD-HSA-TIMP2 as a tumor targeting imaging probe for SPECT and PET","volume":"32","author":"Choi","year":"2011","journal-title":"Biomaterials"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.04.001_bib56","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2967\/jnumed.113.129619","article-title":"Multimodal molecular imaging of integrin \u03b1v\u03b23 for in vivo detection of pancreatic cancer","volume":"55","author":"Trajkovic-Arsic","year":"2014","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.04.001_bib57","first-page":"165","article-title":"68Ga-labeling of RGD peptides and biodistribution","volume":"5","author":"Blom","year":"2012","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.04.001_bib58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cmmi.1523","article-title":"Imaging integrin \u03b1v\u03b23 expression in tumors with an ,F-labeled dimeric RGD peptide","volume":"8","author":"Dijkgraaf","year":"2013","journal-title":"Contrast Media Mol Imaging"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299816300101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299816300101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T21:35:37Z","timestamp":1568324137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299816300101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0001299816300101"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2016.04.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenesis Imaging Using 68Ga-RGD PET\/CT: Therapeutic Implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}